ADVERTISEMENT

Traders Are Skeptical About Bayer’s Chances With Monsanto: Chart

Traders Are Skeptical About Bayer’s Chances With Monsanto: Chart

Traders Are Skeptical About Bayer’s Chances With Monsanto: Chart

(Bloomberg) -- Monsanto Co. closed Wednesday at just $106.76 -- well below Bayer AG’s offer of $128 a share -- as wary traders remained skeptical that the deal will make it to completion. When you place the transaction among other megadeals from the past two years, it doesn’t look good: Both the Pfizer Inc.-Allergan Plc combination and Enterprise Products Partners LP’s bid for Williams Cos. were later terminated. While Anthem Inc.’s $48 billion takeover of Cigna Corp. is still possible, its spread has widened even further in recent months after U.S. regulators sued to block the deal.

To contact the reporter on this story: Elizabeth Fournier in New York at efournier5@bloomberg.net. To contact the editors responsible for this story: Jeffrey McCracken at jmccracken3@bloomberg.net, Elizabeth Wollman